Filed in archive
Drugs, Vaccines and Therapeutics
, Microbiology
by ruth on July 7, 2006

In the July issue of the Journal of Molecular and Cellular Cardiology, the official publication of the International Society for Heart Research, researchers demonstrated for the first time that pretreatment with a clinically relevant dose of rapamycin induces a protective effect against heart attack injury and reduces programmed cell death.
"Rapamycin may one day be beneficial as a potential therapeutic strategy to limit cell death caused by ischemia or reperfusion injury, and possibly long-term prevention of ventricular remodeling - the changes in size, shape and function that may occur to the left ventricle of the heart," said Rakesh C. Kukreja, Ph.D., professor of medicine and Eric Lipman Chair of Cardiology at VCU. Kukreja is lead author of the study.
Researchers also allude to the potential use of rapamycin to coat stents used to treat artery blockage.
For more details on how rapamycin works, refer to the VCU News.
Tags:
antibiotic
cardiovascular
biotech
rapamycin
heart
rapamycin+protect
tissue+damage
against+tissue
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/28127
Mr Wong
Vote for Rapamycin May Protect Heart Against Tissue Damage:
|
Rating: 8.67 out of 3 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







